Navigation Links
ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing
Date:6/21/2010

EXTON, Pa., June 21 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today provided an update on recent progress in Cinryze™ (C1 Esterase Inhibitor [Human]) manufacturing expansion activities.  

ViroPharma is increasing its Cinryze manufacturing capacity through two concurrent efforts.  The first project, the parallel chromatography process, was implemented earlier this year and allows production to run across multiple shifts, effectively doubling the capacity of the current manufacturing line and increasing the amount of drug supply available to patients suffering from hereditary angioedema, or HAE.  The addition of the industrial scale project is expected to significantly increase capacity for Cinryze, providing adequate supply to meet the company's projected demand growth for prophylaxis against attacks of HAE.

ViroPharma today announced that it has filed a Prior Approval Supplement, or PAS, with the U.S. Food and Drug Administration (FDA) seeking approval to commercialize Cinryze manufactured using the industrial scale process. The supplemental data filed with the FDA include in-depth comparability testing at critical manufacturing stages from three conformance lots of industrial scale produced product, as well as stability data and lot release data.  The company believes these data demonstrate that product manufactured at industrial scale meets the required equivalence criteria compared to Cinryze manufactured at current scale.  ViroPharma anticipates receiving approval for product manufactured at industrial scale in the fourth quarter of 2010.  The company expects that the impact to sales from industrial scale manufacturing will begin in 2011.


'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. ViroPharma to Present at the Natixis Bleichroeder Conference
3. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma Announces Discontinuation of HCV-796 Development
6. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
7. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
8. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
9. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
10. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
11. ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... , Nov. 24, 2014 The Female Health ... an investor conference call to discuss its operating results ... 30, 2014 on Tuesday, December 2, 2014 at 11:00 ... report its operating results earlier the same day. ... the conference call by dialing 1-877-374-8416 (international participants dial ...
(Date:11/24/2014)... Nov. 24, 2014  GlySens Incorporated announced today that ... grant from the National Institute of Diabetes and Digestive ... Institutes of Health (NIH).  The grant is intended to ... ICGM™ long term implantable glucose monitoring system.  Final preparations ... is expected to begin before the end of 2014. ...
(Date:11/24/2014)... DEVON, England , Nov. 24, 2014 /PRNewswire/ ... https://www.facebook.com/PifflersUnited announced the release of results ... pain therapy device, in the self-management of fibromyalgia ... the area of worst pain, very significant clinically ... The 140 group members with fibromyalgia used ...
Breaking Medicine Technology:The Female Health Company To Report FY2014 Operating Results on Tuesday, December 2, 2014 2GlySens Incorporated Awarded $2 Million Grant from the National Institutes of Health 2Pifflers United - "Supporting Anyone Living With Chronic/Invisible Illness" Reports ActiPatch Bioelectronic Therapy Relieves Chronic Pain In Fibromyalgia 2Pifflers United - "Supporting Anyone Living With Chronic/Invisible Illness" Reports ActiPatch Bioelectronic Therapy Relieves Chronic Pain In Fibromyalgia 3
... today that eleven presentations or publications on pre-clinical and ... several major tumor types will be made during the ... May 29-June 2, in Orlando, Florida. Abstracts are ... http://www.newscom.com/cgi-bin/prnh/20090227/PH75873LOGO ) Prostate Cancer ...
... (LSE: SHP, Nasdaq: SHPGY ), the global specialty ... of the ADHD medication VYVANSE(R) (lisdexamfetamine dimesylate) CII with the ... X 2), did not alter the median time it took ... reached in the subjects evaluated. In the same study, ...
Cached Medicine Technology:Ascenta Therapeutics Announces Multiple Presentations on AT-101 at 2009 ASCO Annual Meeting 2Ascenta Therapeutics Announces Multiple Presentations on AT-101 at 2009 ASCO Annual Meeting 3New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 2New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 3New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 4New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 5New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 6New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 7New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 8
(Date:11/24/2014)... November 24, 2014 The typical American ... the wrong ingredients. Consistently consuming a diet high in ... stores of excess fat that typically accumulate around the ... rearing its ugly head in the form of love ... dieters make the decision to rid themselves of the ...
(Date:11/24/2014)... (PRWEB) November 24, 2014 "My friend ... was trying to cross the street in his motorized ... never saw him. I came up with this idea ... at night." , He developed the Safety Lites to ... in low-lighting conditions. The device ensures that motorists can ...
(Date:11/23/2014)... 24, 2014 Tbdress.com has recently ... online on Nov. 28, 2014. The special offer will provide ... Tbdress.com is one of the world’s largest women’s dresses retailers, ... colors. People can enjoy great discounts on that day: Everything ... free delivery (for orders above $89). , People can use ...
(Date:11/23/2014)... Locks-Magnetic.com, a notable magnetic locks maker, has released a ... are available at low rates up to 30% off. ... new emergency doors. The emergency door adopts fireproof material ... several colors. All of the products are top-quality guaranteed. ... not as easy as many people think. As ...
(Date:11/23/2014)... November 23, 2014 AngelWeddingDress.com ... a new selection of beach wedding dresses. “If you ... prices, visit AngelWeddingDress.com as soon as possible. Here you ... The sales manager says. , Holding a big marriage ... And choosing a beautiful beach wedding dress is uppermost ...
Breaking Medicine News(10 mins):Health News:Ketogenic Diet is the Perfect Solution for Diet Doc Patients Who Want to Learn How to Lose Weight over the Holidays 2Health News:Ketogenic Diet is the Perfect Solution for Diet Doc Patients Who Want to Learn How to Lose Weight over the Holidays 3Health News:Ketogenic Diet is the Perfect Solution for Diet Doc Patients Who Want to Learn How to Lose Weight over the Holidays 4Health News:Tbdress.com Special Friday Shoes Sales Online Now 2Health News:Beach Wedding Dresses Added to Outstanding Online Dress Company AngelWeddingDress.com 2
... may switch off illness-linked activity in certain areas, researchers ... A technique called cortical brain stimulation improved symptoms and, ... with major depression who had suffered for decades and ... "On average, these individuals had had depression for 27 ...
... dangerous way to seek immunity , , THURSDAY, May 7 (HealthDay ... swine flu in the United States was approaching 1,900, federal ... by person-to-person transmission and not some link to Mexico, as ... ago. , , "Only about 10 percent of confirmed cases ...
... 7 /PRNewswire/ -- Veterinary researchers estimate ... and 45 percent of cats endure arthritic pain. To educate ... treat it -- Morris Animal Foundation (MAF) developed ... with tips on early detection and treatment of ...
... for $9.6 Billion Annually in Funding for George Bush,s Lifesaving ... FY,10 Budget for PEPFAR Obama Budget Calls for $51B for ... YearsWASHINGTON, May 7 AIDS Healthcare Foundation ... the US, which currently provides medical care and services to ...
... Statement from The National Campaign to Prevent Teen ... budget for FY 2010 that was released today ... new teen pregnancy prevention initiative. This includes competitive ... an authorization for $50 million in new mandatory ...
... Conseco, Inc. (NYSE: CNO ) today responded ... subscribers who hold Conseco, Inc. stock vote for eight ... dissident nominee for the ninth director up for election."RMG ... to elect a dissident at Conseco,s upcoming annual meeting ...
Cached Medicine News:Health News:Brain Stimulation Therapy Eases Tough-to-Treat Depression 2Health News:Brain Stimulation Therapy Eases Tough-to-Treat Depression 3Health News:Brain Stimulation Therapy Eases Tough-to-Treat Depression 4Health News:U.S. Swine Flu Count Nears 1,900; Person-to-Person Transmission Now Common 2Health News:U.S. Swine Flu Count Nears 1,900; Person-to-Person Transmission Now Common 3Health News:U.S. Swine Flu Count Nears 1,900; Person-to-Person Transmission Now Common 4Health News:U.S. Swine Flu Count Nears 1,900; Person-to-Person Transmission Now Common 5Health News:U.S. Swine Flu Count Nears 1,900; Person-to-Person Transmission Now Common 6Health News:U.S. Swine Flu Count Nears 1,900; Person-to-Person Transmission Now Common 7Health News:U.S. Swine Flu Count Nears 1,900; Person-to-Person Transmission Now Common 8Health News:U.S. Swine Flu Count Nears 1,900; Person-to-Person Transmission Now Common 9Health News:U.S. Swine Flu Count Nears 1,900; Person-to-Person Transmission Now Common 10Health News:Old Age Isn't a Disease But Arthritis Is - Online Content From Morris Animal Foundation Helps Pet Owners Prevent and Treat Disease That Affects Thousands Each Year 2Health News:Budget: Obama Retreats on Global AIDS, Says AHF 2Health News:President Obama Calls for a New Teen Pregnancy Prevention Initiative 2
Acuvue 2 Colours features a special color-enhancing layer. So you get truly vivid, yet natural color....
... The Vasculight VS system improves the appearance ... freckles), most benign brown pigments, telangiectasias, and ... Intense Pulsed Light (IPLTM) treats pigmentary sun ... unique, combined approach of IPL and the ...
... in an upgradeable skin treatment system. ... of photo-aged skin, removes age spots ... and broken capillaries through a process ... Intense,Pulsed Light (IPLTM) treat facial vascular ...
With a large white surface and a black X in the center, knockout really makes you look the heavyweight....
Medicine Products: